BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15668703)

  • 1. Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer.
    Bando H; Weich HA; Brokelmann M; Horiguchi S; Funata N; Ogawa T; Toi M
    Br J Cancer; 2005 Feb; 92(3):553-61. PubMed ID: 15668703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.
    Kaza E; Ablasser K; Poutias D; Griffiths ER; Saad FA; Hofstaetter JG; del Nido PJ; Friehs I
    Cardiovasc Res; 2011 Feb; 89(2):410-8. PubMed ID: 20935166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
    Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
    Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells.
    Garvin S; Nilsson UW; Dabrosin C
    Br J Cancer; 2005 Oct; 93(9):1005-10. PubMed ID: 16234819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: a study with 193 cases.
    Bando H; Weich HA; Horiguchi S; Funata N; Ogawa T; Toi M
    Oncol Rep; 2006 Mar; 15(3):653-9. PubMed ID: 16465426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
    Robak E; Sysa-Jedrzejewska A; Robak T
    Mediators Inflamm; 2003 Oct; 12(5):293-8. PubMed ID: 14760936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
    Linardou H; Kalogeras KT; Kronenwett R; Kouvatseas G; Wirtz RM; Zagouri F; Gogas H; Christodoulou C; Koutras AK; Samantas E; Pectasides D; Bafaloukos D; Fountzilas G
    Breast Cancer Res; 2012 Nov; 14(6):R145. PubMed ID: 23146280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
    Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
    Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor and its soluble receptors-1 and -2 in iris neovascularization and neovascular glaucoma.
    Noma H; Mimura T; Yasuda K; Shimura M
    Ophthalmologica; 2014; 232(2):102-9. PubMed ID: 24942011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids.
    Hornig C; Barleon B; Ahmad S; Vuorela P; Ahmed A; Weich HA
    Lab Invest; 2000 Apr; 80(4):443-54. PubMed ID: 10780661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer.
    Sallinen H; Heikura T; Koponen J; Kosma VM; Heinonen S; Ylä-Herttuala S; Anttila M
    BMC Cancer; 2014 Sep; 14():696. PubMed ID: 25245329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
    Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
    Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma.
    Ebos JM; Bocci G; Man S; Thorpe PE; Hicklin DJ; Zhou D; Jia X; Kerbel RS
    Mol Cancer Res; 2004 Jun; 2(6):315-26. PubMed ID: 15235107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
    Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
    Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing.
    Saito T; Takeda N; Amiya E; Nakao T; Abe H; Semba H; Soma K; Koyama K; Hosoya Y; Imai Y; Isagawa T; Watanabe M; Manabe I; Komuro I; Nagai R; Maemura K
    FEBS Lett; 2013 Jul; 587(14):2179-85. PubMed ID: 23711375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer.
    Toi M; Bando H; Ogawa T; Muta M; Hornig C; Weich HA
    Int J Cancer; 2002 Mar; 98(1):14-8. PubMed ID: 11857378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
    Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
    Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.